The company’s technology uses data analysis to help primary care providers focus on patients who most need their attention. The financing round consisted of $55 million in equity capital and an anticipated $20 million line of credit, according to a Jan. 26 Pearl news release.
The financing brings the company’s total capital raised to $100 million. Andreessen Horowitz’s Growth Fund and Viking Global Investors led the funding round.
“We are grateful to have the support of such esteemed investors as we continue to build technology that enables physicians to provide better care for their patients and helps our healthcare system transition from volume to value,” Pearl CEO and co-founder Michael Kopko said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
